Tokyo, Japan

Sadayoshi Furuta

This inventor holds 1 USPTO granted patent. Top assignee: Kaken Pharmaceutical Company, Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sadayoshi Furuta. Retrieved from https://idiyas.com/inventor/sadayoshi-furuta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sadayoshi Furuta: Innovator in Medicinal Chemistry

Introduction

Sadayoshi Furuta is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific diseases. His work has the potential to impact the treatment of various medical conditions.

Latest Patents

Furuta holds a patent for a heteroaromatic amide derivative and a medicament containing the same. This innovative compound demonstrates high efficacy for diseases associated with Nav1.7, represented by the general formula (I). His patent showcases his commitment to advancing medical science through innovative solutions.

Career Highlights

Furuta is affiliated with Kaken Pharmaceutical Company, Ltd., where he continues to contribute to research and development in the pharmaceutical industry. His work at Kaken Pharmaceutical highlights his dedication to improving healthcare through innovative drug development.

Collaborations

Furuta has collaborated with notable colleagues, including Issei Akahoshi and Yoshitake Sumikawa. These partnerships reflect the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.

Conclusion

Sadayoshi Furuta's contributions to medicinal chemistry and his innovative patent demonstrate his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…